Merck Wants to Market Cervical Cancer Vaccine For Other Cancers

Merck said on Tuesday that it has submitted an application with U.S. regulators to market its cervical cancer vaccine Gardasil for vaginal and vulvar cancer also.

Gardasil vaccinates against a virus responsible for causing cervical cancer. The company said the U.S. Food and Drug Administration will determine whether it will accept Merck's new application for review within 60 days of its submission.